Pluvo | $5,000,000 | (Mar 3, 2026)
Flux(US) | $27,000,000 | (Mar 3, 2026)
Multitude Insights | $10,000,000 | (Mar 3, 2026)
Certified by Founder
Lodge
Tribune Therapeutics
start up
Norway
- Oslo
- 27/03/2025
- Seed
- $39,883,965
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
- Industry Biotechnology Research
- Website https://www.tribunetx.com/
- LinkedIn https://www.linkedin.com/company/tribune-therapeutics/
Plurio by Elly Analytics | $3,500,000 | (Mar 3, 2026)
Huper Corporation | $1,500,000 | (Mar 3, 2026)
MeltPlan | $10,000,000 | (Mar 3, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)
Procode AI | $4,000,000 | (Mar 3, 2026)
Temple | $54,000,000 | (Mar 3, 2026)
SECONDSENSE | $2,000,000 | (Mar 3, 2026)
Ease Health | $41,000,000 | (Mar 3, 2026)
Smack Technologies Inc. | $32,000,000 | (Mar 3, 2026)